Literature DB >> 6809764

Co-existence of vinculin and a vinculin-like protein of higher molecular weight in smooth muscle.

J R Feramisco, J E Smart, K Burridge, D M Helfman, G P Thomas.   

Abstract

Recently, a protein component of adhesion plaques with a molecular weight of 130,000 (named vinculin) has been purified from smooth muscle and non-muscle cells. As detected by immunological methods, the only vinculin-related polypeptides in fibroblasts are proteins of Mr = 130,000. However, we show here that smooth muscle contains, in addition to vinculin, an apparently distinct protein with a Mr = 152,000 that shares both structural and immunological features with vinculin. Amino acid analysis, peptide mapping, and antibody cross-reaction studies were used to elucidate these similarities. Mr = 152,000 protein seems to be restricted to muscle (mainly or exclusively to smooth muscle). The possibility that vinculin is derived from proteolytic processing of the Mr = 152,000 protein or that the proteins are related by some other type of post-translational modification appears unlikely (although this cannot be completely ruled out) since both proteins are made in a rabbit reticulocyte cell-free translation system when mRNA derived from smooth muscle is used as the template. Both proteins are capable of used as the template. Both proteins are capable of lowering the viscosity of F-actin solutions, although the activity of the Mr = 152,000 protein is stimulated by Ca2+ while the activity of smooth muscle vinculin is not.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809764

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  112 in total

1.  The interaction and colocalization of Sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the Src family kinase p59(fyn).

Authors:  A M Hartmann; O Nayler; F W Schwaiger; A Obermeier; S Stamm
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  Extrasynaptic alpha 7-nicotinic acetylcholine receptor expression in developing neurons is regulated by inputs, targets, and activity.

Authors:  Craig L Brumwell; James L Johnson; Michele H Jacob
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

3.  A cis-acting element in the promoter region of the murine c-myc gene is necessary for transcriptional block.

Authors:  H Miller; C Asselin; D Dufort; J Q Yang; K Gupta; K B Marcu; A Nepveu
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

4.  The role of extracellular matrix stiffness in regulating cytoskeletal remodeling via vinculin in synthetic smooth muscle cells.

Authors:  Kai Shen; Harshavardhan Kenche; Hua Zhao; Jinping Li; Jasimine Stone
Journal:  Biochem Biophys Res Commun       Date:  2018-11-28       Impact factor: 3.575

5.  Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression.

Authors:  M G Spillantini; L Aloe; E Alleva; R De Simone; M Goedert; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  A role for the intermediate affinity IL-2R in the protection against glucocorticoid-induced apoptosis.

Authors:  A Rebollo; C Pitton; A García; J Gómez; A Silva
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

7.  Sucrose mimics the light induction of Arabidopsis nitrate reductase gene transcription.

Authors:  C L Cheng; G N Acedo; M Cristinsin; M A Conkling
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

8.  Insulin regulation of rat growth hormone gene transcription.

Authors:  S Yamashita; S Melmed
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

9.  Mutational analysis of the lac regulatory region: second-site changes that activate mutant promoters.

Authors:  R K Rothmel; J E LeClerc
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

Review 10.  Biochemical mechanisms in colon xenografts: thymidylate synthase as a target for therapy.

Authors:  P J Houghton; J A Houghton; B J Hazelton; S Radparvar
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.